Stock A003520 YUNGJIN PHARM. CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Yungjin Pharm. Co., Ltd.

Equities

A003520

KR7003520004

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-05-02 EDT 		5-day change 1st Jan Change
2,125 KRW +0.24% Intraday chart for Yungjin Pharm. Co., Ltd. +2.16% 0.00%
2023 Yungjin Pharm. Co., Ltd. announced that it has received KRW 30.3 billion in funding from a group of investors CI
2023 Yungjin Pharm. Co., Ltd. announced that it expects to receive KRW 30.3 billion in funding from a group of investors CI

Business Summary

Yungjin Pharma Co Ltd is a Korea-based company principally engaged in the manufacture and distribution of pharmaceutical products. The Company mainly manufactures and sells pharmaceutical products including antibiotics, respiratory drugs, anti-infective drugs, antipyretics, analgesics, central nervous system (CNS) drugs, gastrointestinal (GI) drugs, cardiovascular (CV) drugs, antihistamines, antifungals, antidiabetics, vitamin nutrients, antibiotic raw materials, and others. The Company also engages in the leasing of real estates.

Number of employees: 574

Sales per Business

KRW in Million2022Weight2023Weight Delta
Pharmaceutical
100.0 %
218,381 100.0 % 234,902 100.0 % +7.57%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
89.7 %
194,213 88.9 % 210,785 89.7 % +8.53%
Japan
8.3 %
20,865 9.6 % 19,389 8.3 % -7.07%
Taiwan
1.6 %
2,194 1.0 % 3,694 1.6 % +68.34%
Others
0.4 %
1,109 0.5 % 1,035 0.4 % -6.63%

Managers

Managers TitleAgeSince
Gi-Soo Lee CEO
 Chief Executive Officer 58 22-03-23
Hyo-Jin Oh BRD
 Director/Board Member 52 -

Members of the board

Members of the board TitleAgeSince
Chang-Joon Song BRD
 Director/Board Member 54 17-03-23
Hyo-Jin Oh BRD
 Director/Board Member 52 -
Gi-Soo Lee CEO
 Chief Executive Officer 58 22-03-23
Young-Seok So BRD
 Director/Board Member 57 -
Bong-Nyeon Kim BRD
 Director/Board Member 57 22-03-23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 182,892,731 86,949,916 ( 47.54 %) 277 ( 0.000151 %) 47.54 %

Shareholders

NameEquities%Valuation
KT&G CORPORATION
52.45 %
95,928,655 52.45 % 153 M ₩
Kyobo AXA Investment Managers Co., Ltd.
0.0419 %
76,662 0.0419 % 122 432 ₩
Yungjin Pharm Co., Ltd. Employee Stock Ownership Association
0.007591 %
13,883 0.007591 % 22 172 ₩
Dimensional Fund Advisors Ltd.
0.006814 %
12,462 0.006814 % 19 902 ₩
DFA Australia Ltd.
0.004149 %
7,589 0.004149 % 12 120 ₩
Mirae Asset Global Investments Co., Ltd.
0.003319 %
6,071 0.003319 % 9 696 ₩
Korea Investment Management Co., Ltd.
0.000336 %
614 0.000336 % 981 ₩
Kiwoom Asset Management Co., Ltd.
0.000244 %
447 0.000244 % 714 ₩
YUNGJIN PHARM. CO., LTD.
0.000151 %
277 0.000151 % 442 ₩

Holdings

NameEquities%Valuation
YUNGJIN PHARM. CO., LTD.
0.00%
 277 0.00% 442 $

Company contact information

Yungjin Pharm. Co., Ltd.

13 Olympic-ro 35da-gil Songpa-gu

05510, Seoul

+

http://www.yungjin.co.kr
address Yungjin Pharm. Co., Ltd.(A003520)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
YUNGJIN PHARM. CO., LTD. Stock Yungjin Pharm. Co., Ltd.
0.00% 287M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.08% 662B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.85% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.65% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-11.12% 194B
AMGEN INC. Stock Amgen Inc.
+8.08% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A003520 Stock
  4. Company Yungjin Pharm. Co., Ltd.